Literature DB >> 21804369

Risk factors of renal failure and severe complications in patients with emphysematous pyelonephritis-a single-center 15-year experience.

Yen-Chung Lin1, Yi-Chun Lin, Hong-Da Lin, Liang-Yu Lin.   

Abstract

INTRODUCTION: Emphysematous pyelonephritis (EPN) is a rare but severe infection of renal parenchyma. Risk factors of renal failure in patients survived from EPN are not clear.
METHODS: The authors retrospectively reviewed the patients with a diagnosis of EPN at Taipei Veterans General Hospital from January 1, 1995, to December 31, 2009. The authors analyzed the demographic, characteristics and the treatment modalities of those patients. The renal function of survivors after EPN episode had been followed for 1 year.
RESULTS: A total of 23 patients with a mean age of 62.8 ± 17.1 years were enrolled. Mean hospital duration was 31.8 ± 21.6 days. Fifteen (65.2%) patients had a history of diabetes mellitus. Mean serum HbA1c level among the diabetic patients was 11.7 ± 3.3. More than half of patients had Escherichia coli in culture. Eleven (47.8%) patients received antibiotic treatment alone. Twelve (52.2%) patients received the concurrent percutaneous drainage and antibiotics. The overall mortality rate was 8.6%. Shock, long hospital duration and the extensive classes of computed tomography image were correlated with poor outcome. A higher initial serum creatinine level (2.8 ± 1.4 versus 1.6 ± 0.8, P = 0.015) and receiving invasive therapy (67.7% versus 12.5%, P = 0.017) significantly contributed to chronic kidney disease in the follow-up. Shock is also an independent predictor of the poor outcome in those patients (P = 0.026).
CONCLUSIONS: In the current era, antibiotics alone provide a high success rate for the treatment of EPN. Invasive therapy is a predictor of development of chronic kidney disease. Initial resuscitation and antibiotic therapy are still the cornerstone and have the benefit of the preservation of renal function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21804369     DOI: 10.1097/MAJ.0b013e318225b891

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

Review 2.  A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.

Authors:  Rajeev Desai; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2022-02-01       Impact factor: 2.370

Review 3.  Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach.

Authors:  Omar M Aboumarzouk; Owen Hughes; Krishna Narahari; Richard Coulthard; Howard Kynaston; Piotr Chlosta; Bhaskar Somani
Journal:  Arab J Urol       Date:  2013-11-19

4.  Emphysematous pyelonephritis: the impact of urolithiasis on disease severity.

Authors:  Thomas H Sanford; Frank Myers; Thomas Chi; Herman S Bagga; Andrew G Taylor; Marshall L Stoller
Journal:  Transl Androl Urol       Date:  2016-10

5.  Emphysematous Pyelonephritis and Cystitis: Unusual Adverse Events during Concurrent Chemoradiotherapy for Lung Cancer.

Authors:  Tetsuya Yokoyama; Seiji Shinozaki; Hidenobu Arimura; Keita Nakatomi; Hiroshi Wataya
Journal:  Case Rep Oncol       Date:  2017-03-09

Review 6.  Emphysematous pyelonephritis and cystitis in a patient with uremia and anuria: A case report and literature review.

Authors:  Qiang Wang; Meifeng Sun; Chengjun Ma; Hailin Lv; Peng Lu; Qi Wang; Guangyi Liu; Zhao Hu; Yanxia Gao
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

7.  Emphysematous pyelonephritis: Does a standard management algorithm and a prognostic scoring model optimize patient outcomes?

Authors:  Amit Jain; Ramanitharan Manikandan; Lalgudi Narayanan Dorairajan; Sreerag Kodakkattil Sreenivasan; Sriharsha Bokka
Journal:  Urol Ann       Date:  2019 Oct-Dec

8.  Mortality in emphysematous pyelonephritis: Can we reduce it further by using a protocol-based treatment? The results of a prospective study.

Authors:  Kalyanaram Kone; Naveen Thimiri Mallikarjun; M D R K Keerthi Rams
Journal:  Urol Ann       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.